188 related articles for article (PubMed ID: 31138311)
1. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
[TBL] [Abstract][Full Text] [Related]
2. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits.
Zhou W; Yun Z; Wang T; Li C; Zhang J
Int J Biol Macromol; 2021 Sep; 187():800-810. PubMed ID: 34293363
[TBL] [Abstract][Full Text] [Related]
3. BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer.
Wang H; Gao L; Qi M; Su P; Xiong X; Zhao J; Hu J; Han B
Biochem Biophys Res Commun; 2021 Jan; 537():22-28. PubMed ID: 33383560
[TBL] [Abstract][Full Text] [Related]
4. CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c.
Jiao M; Qi M; Zhang F; Hu J; Feng T; Zhao M; Li X; Liu H; Teng W; Zhang J; Liu Z; Zhang L; Wu Z; Han B
Prostate; 2019 Aug; 79(11):1294-1303. PubMed ID: 31111526
[TBL] [Abstract][Full Text] [Related]
5. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
[TBL] [Abstract][Full Text] [Related]
6.
Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
[TBL] [Abstract][Full Text] [Related]
7. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer.
Li X; Wu JB; Li Q; Shigemura K; Chung LW; Huang WC
Oncotarget; 2016 Mar; 7(11):12869-84. PubMed ID: 26883200
[TBL] [Abstract][Full Text] [Related]
8. Insights into homeobox B9: a propeller for metastasis in dormant prostate cancer progenitor cells.
Sui Y; Hu W; Zhang W; Li D; Zhu H; You Q; Zhu R; Yi Q; Tang T; Gao L; Zhu S; Yang T
Br J Cancer; 2021 Sep; 125(7):1003-1015. PubMed ID: 34247196
[TBL] [Abstract][Full Text] [Related]
9. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
11. BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C.
Zhang Y; Gao X; Yi J; Sang X; Dai Z; Tao Z; Wang M; Shen L; Jia Y; Xie D; Cheng H; Liu Z; Liu P
Cell Death Dis; 2021 Jan; 12(1):12. PubMed ID: 33414468
[TBL] [Abstract][Full Text] [Related]
12. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract][Full Text] [Related]
13. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
15. p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer.
Sui X; Cai J; Li H; He C; Zhou C; Dong Y; Chen L; Zhang B; Wang Y; Zhang Y; Qiu Y; Zhang Y; Zhao Y; Huang Y; Shen Y; Wu H; Xiao J; Mason C; Zhu Q; Han S
Cell Death Dis; 2018 May; 9(5):523. PubMed ID: 29743605
[TBL] [Abstract][Full Text] [Related]
16. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
17. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
[TBL] [Abstract][Full Text] [Related]
18. BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
Siddique HR; Parray A; Tarapore RS; Wang L; Mukhtar H; Karnes RJ; Deng Y; Konety BR; Saleem M
PLoS One; 2013; 8(5):e60664. PubMed ID: 23671559
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
Wu KJ; Yang MH
Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
[TBL] [Abstract][Full Text] [Related]
20. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]